Dare Bioscience DARE
NASDAQ DARE
$0.82 +0.01 (+1.74%)
As of: Aug 21, 2026 · 11:50 AM EDT

Dare Bioscience (DARE) Operating Margin Growth (3y) (2025)

Dare Bioscience (DARE) Operating Margin Growth (3y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.90 Bn 132.05 Bn 2.84 Bn -377.00
2 Regeneron Pharmaceuticals 86.70 Bn 78.71 Bn 3.93 Bn -204.00
3 Argenx Se 65.73 Bn 60.55 Bn 1.37 Bn -537.00
4 Moderna 58.33 Bn 53.19 Bn 52.00 Mn -1,934.00
5 BeOne Medicines 42.16 Bn 37.07 Bn 1.53 Bn 7,261.00
6 Alnylam Pharmaceuticals 31.72 Bn 28.42 Bn 992.69 Mn 9,003.00
7 BioNTech SE 28.27 Bn 9.88 Bn 668.28 Mn -11,254.00
8 Insmed 27.61 Bn 26.45 Bn 358.27 Mn 30,461.00
9 Royalty Pharma 27.25 Bn 26.41 Bn - -2,649.00
10 Dare Bioscience 12.26 Mn -358,795.25 -132,343.00 -

Historic Data

Download Data
DateValue
Jun 30, 2025 1.81 Mn